AFF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.491000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.971400E-01
Normal-vs-Stage2
3.307200E-01
Normal-vs-Stage3
6.141600E-02
Normal-vs-Stage4
5.494400E-01
Stage1-vs-Stage2
4.634000E-01
Stage1-vs-Stage3
3.532100E-02
Stage1-vs-Stage4
2.449000E-01
Stage2-vs-Stage3
9.185600E-02
Stage2-vs-Stage4
1.321900E-02
Stage3-vs-Stage4
8.875900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.286200E-01
Normal-vs-AfricanAmerican
8.694000E-01
Normal-vs-Asian
2.448000E-01
Caucasian-vs-AfricanAmerican
3.227200E-01
Caucasian-vs-Asian
3.445600E-01
AfricanAmerican-vs-Asian
2.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.394400E-01
Normal-vs-Female
3.769000E-01
Male-vs-Female
7.102600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.946000E-01
Normal-vs-Age(41-60Yrs)
7.340800E-01
Normal-vs-Age(61-80Yrs)
2.251000E-01
Normal-vs-Age(81-100Yrs)
1.471380E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.733000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.822600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.169200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.257400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.557900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.407000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.654430E-01
Normal-vs-Daily Drinker
9.368100E-02
Normal-vs-Weekly Drinker
2.835200E-01
Normal-vs-Occasional Drinker
3.506200E-01
Normal-vs-Social Drinker
6.422000E-01
Non Drinker-vs-Daily Drinker
6.502000E-01
Non Drinker-vs-Weekly Drinker
9.182000E-01
Non Drinker-vs-Occasional Drinker
3.684600E-01
Non Drinker-vs-Social Drinker
1.284750E-01
Daily Drinker-vs-Weekly Drinker
6.498800E-01
Daily Drinker-vs-Occasional Drinker
1.937630E-01
Daily Drinker-vs-Social Drinker
6.571700E-02
Weekly Drinker-vs-Occasional Drinker
5.439800E-01
Weekly Drinker-vs-Social Drinker
2.753600E-01
Occasional Drinker-vs-Social Drinker
5.079400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.411600E-02
Normal-vs-Grade 2
1.521940E-02
Normal-vs-Grade 3
1.415530E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.787000E-01
Grade 1-vs-Grade 3
2.263000E-01
Grade 1-vs-Grade 4
8.411600E-02
Grade 2-vs-Grade 3
7.083600E-01
Grade 2-vs-Grade 4
1.521940E-02
Grade 3-vs-Grade 4
1.415530E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.095640E-01
Normal-vs-NonDiabetic
2.486000E-01
Diabetic-vs-NonDiabetic
3.117600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.770190E-01
Normal-vs-NoPancreatitis
2.317200E-01
Pancreatitis-vs-NoPancreatitis
9.569600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.006400E-01
Normal-vs-N1
3.600400E-01
N0-vs-N1
6.748400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.050400E-01
Normal-vs-TP53-NonMutant
5.780400E-01
TP53-Mutant-vs-TP53-NonMutant
5.695000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
